Michael Beaulieu | Integra LifeSciences Holdings Corp. |
Peter J. Arduini | Integra LifeSciences Holdings Corp. |
Glenn G. Coleman | Integra LifeSciences Holdings Corp. |
Sravan Emany | Integra LifeSciences Holdings Corp. |
David L. Turkaly | JMP Securities LLC |
Jonathan Demchick | Morgan Stanley & Co. LLC |
J.P. McKim | Piper Jaffray & Co. |
Robbie J. Marcus | JPMorgan Securities LLC |
Shagun Singh | Wells Fargo Securities LLC |
Jayson T. Bedford | Raymond James & Associates, Inc. |
Raj Denhoy | Jefferies LLC |
Craig William Bijou | Cantor Fitzgerald Securities |
Travis Steed | Bank of America Merrill Lynch |
Steven Lichtman | Oppenheimer & Co., Inc. |
Ryan Zimmerman | BTIG LLC |
Good day everyone and welcome to the Integra LifeSciences First Quarter 2018 Financial Results Conference Call.
As a reminder, today's call is being recorded. At this time, I would like to turn the conference over to Mike Beaulieu, Director of Investor Relations. Please go ahead, sir.
Thank you, Brei.